anayamalik, Author at European Medical Journal - Page 62 of 97

Elevated Melanoma Risk in Childhood Cancer Survivors

A recent study has revealed that adult survivors of childhood cancer face a significantly elevated risk of developing melanoma, underscoring the necessity for vigilant long-term monitoring and tailored preventive strategies.

Alarming Rise in US Female Physician Suicides

A troubling trend showing female physicians in the United States are dying by suicide at significantly higher rates than their counterparts in the general population has been exposed in a recent cohort study.

Lung Cancer Screening: Comorbidity and Diversity Challenges Revealed

A recent cohort study has highlighted significant disparities in comorbidity profiles among patients undergoing low-dose computed tomography (LDCT) for lung cancer screening.

Menthol Cigarettes Carry Higher Mortality Risk Compared to Non-Menthol

Smoking menthol-flavored cigarettes is associated with higher mortality risks compared to non-menthol cigarettes according to a new study.

Managing PTLD in Pediatric Liver Transplants

The significant concern of Epstein-Barr virus (EBV) in pediatric liver transplant recipients due to its strong association with post-transplant lymphoproliferative disorder (PTLD) has been explored in a recently published study.

RA Drugs Show Promise Despite Kidney Issues

Explore the efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease, highlighting potential risks like deep vein thrombosis.

Dupilumab Shows Cardiometabolic Benefits in Atopic Dermatitis

A recent global retrospective cohort study has demonstrated that dupilumab, a monoclonal antibody used to treat atopic dermatitis (AD), offers a favorable cardiometabolic safety profile compared to traditional systemic agents such as methotrexate and cyclosporine.

Tramadol and Parkinson’s: New Pain Insights

Patients with Parkinson’s disease (PD) are five times more likely to experience chronic pain than their age-matched peers, according to a new study analyzing electronic medical records from over 250 million patients.

Integrative Sleep Medicine Enhances Cancer Care: MCM 2025

Integrative sleep medicine is revolutionizing cancer care, as highlighted at the 21st Annual Miami Cancer Meeting (MCM) in Tampa, Florida, this January.

New mRNA Vaccine Boosts TB Protection

A novel lipid nanoparticle (LNP)-mRNA vaccine has demonstrated strong immune responses and enhanced protection against Mycobacterium tuberculosis, the leading cause of infectious mortality worldwide.